CRISPR Therapeutics Announces the Appointment of Jon Terrett, Ph.D. to Head of Immuno-Oncology Research and Translation
28 févr. 2017 08h00 HE
|
CRISPR Therapeutics AG
Experienced leader with extensive experience in immuno-oncologyDedicated unit in immuno-oncology to accelerate efforts BASEL, Switzerland and CAMBRIDGE, Mass., Feb. 28, 2017 (GLOBE NEWSWIRE) --...
CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology
16 déc. 2016 08h00 HE
|
CRISPR Therapeutics AG
BASEL, Switzerland, CAMBRIDGE, Mass., BERKELEY, Calif. and DUBLIN, Ireland, Dec. 16, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), Intellia Therapeutics (NASDAQ:NTLA), Caribou...